of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
IVF
Interventions
DRUG

Myoinositol

an enzymatic isoform of inositol and belongs to the vitamin B complex family

DRUG

Co-Enzyme Q10

a lipid-soluble quinone, acting as an effective antioxidant,

DRUG

Melatonin

an indoleamine with low molecular weight that is synthesized by different cells and organs in the body. More importantly, melatonin is an outstanding antioxidant

DRUG

Folic acid

control

Trial Locations (1)

62511

Beni-suef university Hospital, Banī Suwayf

All Listed Sponsors
lead

Beni-Suef University

OTHER